Event Date: Aug 08, 2018
Medications allow Canadians to live longer and healthier lives. However, some medications may carry more risk than benefit, especially with aging. The burden of medication on cognitive health cannot be ignored and should be one of the first things assessed when cognitive impairment is diagnosed in a patient.
Come learn about medications which may not necessarily be helping patients and how deprescribing (reducing or stopping medications that may not be beneficial or may be causing harm) can represent an interesting approach.
This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA).
Camille Gagnon is the Assistant Director of the Canadian Deprescribing Network. She is a clinical pharmacist with experience in family health, clinical program management, community pharmacy, education and pharmacogeriatry. She is a passionate medication safety advocate.